Every Form 4 that Celanese Corp Del (CE) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow CE and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CE filings page.
Celanese Corp (CE) reports that SVP & CFO Chuck Kyrish purchased company common stock on August 14, 2026. Three non-derivative transactions labeled “Purchase in open market or private transaction” total 2,300 shares, at per-share prices ranging from $45.5050 to $45.5299, all held as direct ownership. The Rule 10b5-1 checkbox was not marked, so these purchases were not affirmed as made under a trading plan.
Ashley B. Duffie, SVP & GC of Celanese Corp, purchased 600 shares of common stock on 2026-08-11 in an open market or private transaction at $45.60 per share. Following this trade, Duffie directly holds 31,925 shares and indirectly holds 691.4868 shares through a 401(k) Plan.
Celanese Corp SVP Mark Christopher Murray purchased additional company shares. On 2026-08-11, he bought 2,153 shares of Common Stock in a purchase in open market or private transaction at $45.5199 per share. Following this transaction, he directly holds 30,432 shares of Celanese Common Stock.
Kissire Deborah J. reported acquisition or exercise transactions in this Form 4 filing.
Celanese Corp director Deborah J. Kissire received an award of 6.277 shares of phantom stock on August 10, 2026. Each phantom share represents the right to receive one share of common stock and reflects dividend equivalents on compensation deferred under the company’s 2008 Deferred Compensation Plan. Following this award, Kissire holds 9,310.054 phantom stock units, which are payable in common stock after her service as a director ends, as provided in the plan.
Rucker Kim K.W. reported acquisition or exercise transactions in this Form 4 filing.
Celanese Corp director Kim K.W. Rucker received an award of 8.705 phantom stock units on 2026-08-10, recorded at $44.4600 per unit. Each phantom stock unit represents the right to receive one share of common stock and reflects dividend equivalents on compensation deferred under the company’s 2008 Deferred Compensation Plan. Following this award, Rucker holds 12,909.224 phantom stock units, which are payable in shares of common stock after her service as a director ends, as provided in the plan.
Celanese Corp director Edward G. Galante reported two equity-based compensation awards. He received an annual grant of 1,930 shares of Common Stock as fully vested restricted stock units under the company's 2018 Global Incentive Plan, granted as compensation for prior service as Chair of the Board, bringing his direct Common Stock holdings to 27,983 shares. He also acquired 4.595 shares of phantom stock as dividend equivalents on deferred compensation under the 2008 Deferred Compensation Plan, increasing his phantom stock balance to 6,814.817 shares, payable in Common Stock following the end of his board service.
Celanese Corp director Kathryn Hill reported an acquisition of 0.7710 shares of phantom stock on 2026-08-10 at a reference value of $44.46 per share. These phantom stock units represent dividend equivalents on compensation deferred under Celanese’s 2008 Deferred Compensation Plan and are payable in an equivalent number of common shares as provided in the plan, bringing her reported phantom stock balance to 1,142.5400 units held directly.
Chinn Bruce E. reported acquisition or exercise transactions in this Form 4 filing.
Celanese Corp director Bruce E. Chinn received an annual equity grant of 2,975 shares of common stock in the form of restricted stock units. These units were awarded at no cash cost to him under the Company's Amended and Restated 2018 Global Incentive Plan and vest in full on the one-year anniversary of the grant date.
After this compensation-related grant, Chinn directly holds 7,261 shares of Celanese common stock. This filing reflects routine director equity compensation rather than an open-market purchase or sale.
Celanese Corp director Anne P. Noonan reported receiving a grant of 2,975 shares of common stock as a compensation award. The Form 4 shows this as a grant or award acquisition at a price of $0.00 per share, bringing her directly held position to 2,975 shares.
A footnote explains this is an annual grant of restricted stock units under Celanese’s Amended and Restated 2018 Global Incentive Plan, which vest in full on the one-year anniversary of the grant date.
Celanese Corp director Michael Koenig reported routine equity compensation activity. On May 11, 2026, he acquired 2,975 shares of Common Stock as a grant/award of restricted stock units with no cash paid per share. According to the footnotes, these units were granted under the Company’s Amended and Restated 2018 Global Incentive Plan and will vest in full on the one-year anniversary of the grant date.
On May 9, 2026, 1,013 shares of Common Stock were disposed of at $57.51 per share to cover taxes due upon vesting and settlement of performance-based restricted stock units, a non-market tax-withholding transaction. After these transactions, Koenig directly holds 8,320 shares of Celanese common stock.
MOORTHY GANESH reported acquisition or exercise transactions in this Form 4 filing.
Celanese Corp director Ganesh Moorthy reported an annual equity compensation grant in the form of restricted stock units. He received 2,975 shares of Common Stock as a grant or award at a stated price of $0.00 per share under the company’s Amended and Restated 2018 Global Incentive Plan. These restricted stock units vest in full on the one-year anniversary of the grant date, meaning the shares become fully owned after that period. Following this award, Moorthy directly holds 8,990 shares of Celanese common stock and indirectly holds 3,000 shares through the Ganesh and Hema Moorthy Revocable Living Trust. This filing reflects routine director compensation rather than an open-market purchase or sale.
Celanese Corp director Deborah J. Kissire reported compensation-related equity movements. On May 9, 2026, 3,376 Restricted Stock Units vested, and she deferred the resulting 3,376 shares of Common Stock into 3,376 shares of phantom stock under the company’s 2008 Deferred Compensation Plan, leaving 1,100 Common shares directly held.
On May 11, 2026, she received an annual grant of 2,975 restricted stock units under the Amended and Restated 2018 Global Incentive Plan, which vest in full one year after grant. She also received 2.984 additional phantom stock shares as dividend equivalents, bringing her phantom stock balance to 9,303.777 units, each representing the right to receive one share of Common Stock.
Celanese Corp director Kim K.W. Rucker reported routine equity compensation and deferral activity. On May 9, 2026, 3,376 Restricted Stock Units vested and were exchanged for 3,376 shares of phantom stock under the company’s 2008 Deferred Compensation Plan, in place of receiving common shares.
On the same date, the director’s common stock position decreased by 3,376 shares to reflect this deferral, while the phantom stock balance increased by the same amount. On May 11, 2026, the director received an annual grant of 2,975 restricted stock units in common stock and an additional 4.796 shares of phantom stock as dividend equivalents.
After these transactions, the director directly holds 3,031 shares of Celanese common stock and 12,900.519 shares of phantom stock, each phantom share representing the right to receive one share of common stock in the future. These are compensation and deferral arrangements rather than open-market stock purchases or sales.
Celanese Corp director Kathryn Hill received new equity-based compensation on May 11, 2026. She was granted 2,975 shares of Common Stock in the form of restricted stock units under the company’s Amended and Restated 2018 Global Incentive Plan, which vest in full one year after the grant date. Following this award, she directly holds 19,783.48 shares of Common Stock.
Hill also acquired 0.575 shares of phantom stock as dividend equivalents on compensation deferred under the company’s 2008 Deferred Compensation Plan. Each phantom share represents the right to receive one share of Common Stock, bringing her phantom stock balance to 1,141.769 units. These are compensation-related grants, not open‑market purchases.
Celanese Corp director Christopher J. Kuehn reported equity compensation and a deferral election, not open-market trading. On May 11, he received 2,975 shares of Common Stock as a grant with a reported price of $0.00 per share, leaving him with 2,975 Common shares directly owned.
On May 9, 3,376 Restricted Stock Units vested, and instead of taking delivery of 3,376 Common shares, he exchanged them for 3,376 shares of phantom stock under Celanese’s 2008 Deferred Compensation Plan. Each phantom stock share represents the right to receive one Common share, payable in stock at a later date or upon his termination as a director.
Celanese Corp director Edward G. Galante received new equity-based compensation. On May 11, 2026, he was granted 4,676 shares of Common Stock in the form of restricted stock units under the Amended and Restated 2018 Global Incentive Plan. These units vest in full on the one-year anniversary of the grant date.
He also acquired 3.429 shares of phantom stock as dividend equivalents on deferred compensation under the 2008 Deferred Compensation Plan. Each phantom stock unit represents the right to receive one share of Common Stock and becomes payable in shares after his service as a director ends. Following these awards, he directly holds 26,053 shares of Common Stock and 6,810.222 phantom stock units.
Celanese Corp director Kim K.W. Rucker reported a small compensation-related award of phantom stock tied to common shares. On this Form 4, Rucker acquired 5.633 units of phantom stock, each representing the right to receive one share of Celanese common stock. These units reflect dividend equivalents on compensation deferred under the company’s 2008 Deferred Compensation Plan. After this award, Rucker holds a total of 9,519.723 phantom stock units, which will be payable in common stock according to the terms of the plan.
Kissire Deborah J. reported acquisition or exercise transactions in this Form 4 filing.
Celanese Corp director Deborah J. Kissire received an automatic award of 3.505 shares of phantom stock tied to deferred compensation dividends. Each phantom stock unit represents the right to receive one share of Celanese common stock under the company’s 2008 Deferred Compensation Plan. Following this grant, she holds a total of 5,924.793 phantom stock units directly, which will eventually be settled in common shares as provided in the plan. This filing reflects routine compensation-related accruals rather than an open-market stock purchase or sale.
Celanese Corp director Jay V. Ihlenfeld received a small phantom stock award as part of deferred compensation. On this date, he acquired 6.0600 phantom stock units, each representing the right to receive one share of Celanese common stock. These units reflect dividend equivalents on compensation deferred under the company’s 2008 Deferred Compensation Plan and will be paid in common shares according to that plan’s terms. Following this grant, Ihlenfeld directly holds a total of 10241.1190 phantom stock units linked to Celanese common stock.
Celanese Corp director Kathryn Hill reported an acquisition of 0.675 shares of phantom stock on March 10, 2026. This entry reflects dividend equivalents credited on compensation deferred under Celanese’s 2008 Deferred Compensation Plan. Each phantom share represents the right to receive one share of Celanese common stock, bringing her total phantom holdings to 1,141.194 shares.
GALANTE EDWARD G reported acquisition or exercise transactions in this Form 4 filing.
Celanese Corp director Edward G. Galante received a small grant of 4.028 phantom stock units on Celanese common stock. These units were credited as dividend equivalents on compensation he deferred under the company’s 2008 Deferred Compensation Plan and are settled in common shares under that plan’s terms.
Following this award, Galante holds a total of 6,806.793 phantom stock units tied to Celanese common stock. This filing reflects a routine, compensation-related accrual rather than an open-market purchase or sale of shares.
Richardson Scott A reported acquisition or exercise transactions in this Form 4 filing.
Celanese Corp CEO Scott A. Richardson reported equity awards on February 27, 2026. He was granted 70,663 nonqualified stock options and 50,623 time-based restricted stock units under the company’s 2018 Global Incentive Plan, vesting in installments from February 15, 2027 through February 15, 2029. He also reports 595.4436 common shares held indirectly through a 401(k) plan.
Murray Mark Christopher reported acquisition or exercise transactions in this Form 4 filing.
Celanese Corp senior vice president Mark Christopher Murray received new equity awards. On February 27, 2026, he was granted 14,561 nonqualified stock options with time-based vesting and 10,431 shares of common stock in the form of restricted stock units under the company’s 2018 Global Incentive Plan. The options and RSUs vest in three annual tranches from February 15, 2027 through February 15, 2029, subject to continued employment.
McGilvray Aaron M reported acquisition or exercise transactions in this Form 4 filing.
Celanese Corp Chief Accounting Officer Aaron M. McGilvray received new equity awards. He was granted nonqualified stock options for 2,355 shares and time-based restricted stock units covering 1,687 shares of common stock at no cost.
The RSUs vest 33% on February 15, 2027 and 2028, and 34% on February 15, 2029, if employment continues. The options vest in three annual installments of 33%, 33%, and 34% beginning February 15, 2027. He also reports indirect holdings through a 401(k) plan.
Celanese Corp reported that its SVP & CFO, Chuck Kyrish, received an equity compensation grant. He acquired 15,678 time-based restricted stock units, each convertible into one share of common stock under the company’s Amended and Restated 2018 Global Incentive Plan.
Kyrish was also granted 21,884 time-based nonqualified stock options under the same plan. The RSUs vest in portions of 33%, 33%, and 34% on February 15 of 2027, 2028, and 2029, while the options vest in three annual installments of 33%, 33%, and 34% beginning February 15, 2027, all subject to continued employment.
Elliott Todd L reported acquisition or exercise transactions in this Form 4 filing.
Celanese Corp senior vice president Todd L. Elliott reported equity awards that increase his direct holdings. On February 27, 2026, he received 17,558 nonqualified stock options and 12,579 time-based restricted stock units (RSUs) at no cash cost.
The RSUs, each representing one future share of common stock, vest with 33% on February 15, 2027, 33% on February 15, 2028, and 34% on February 15, 2029, subject to continued employment. The stock options vest on the same 33%, 33%, 34% annual schedule beginning February 15, 2027.
Duffie Ashley B reported acquisition or exercise transactions in this Form 4 filing.
Celanese Corp senior vice president and general counsel Ashley B. Duffie reported equity awards that increase her stake in the company. She received a grant of 14,561 nonqualified stock options and 10,431 shares of common stock, both awarded at a stated price of $0.00 per share.
The options are time-based employee stock options granted under the company’s Amended and Restated 2018 Global Incentive Plan and vest in three installments of 33%, 33% and 34% beginning on February 15, 2027. The common stock award consists of time-based restricted stock units, each representing one share of common stock, vesting 33% on each of February 15, 2027 and February 15, 2028, and 34% on February 15, 2029, all subject to continued employment.
Celanese Corp CEO & President Scott A. Richardson reported equity compensation activity in the form of performance-based restricted stock units. On February 15, 2026, he acquired 3,336 shares of common stock at $0.00 per share upon the vesting and settlement of PRSUs originally granted on February 8, 2023.
To cover related tax obligations, 989 shares of common stock were disposed of at $59.12 per share through a tax-withholding transaction rather than an open-market sale. Following these transactions, his direct holdings increased to 72,795.703 common shares, with an additional 596.1055 shares held indirectly through a 401(k) plan.
Celanese Corp senior vice president Mark Christopher Murray reported equity compensation activity involving company common stock. On February 15, 2026, he acquired 1,205 shares at no cost through the vesting and settlement of performance-based restricted stock units originally granted on February 8, 2023.
On the same date, 357 shares were disposed of at a price of $59.12 per share to cover taxes owed on the PRSU vesting. After these transactions, he directly held 17,848 common shares of Celanese.
Celanese Corp Chief Accounting Officer Aaron M. McGilvray reported routine equity award activity in company common stock. On February 15, 2026, he acquired 173 shares at $0.00 per share from the vesting and settlement of performance-based restricted stock units granted in 2023. On the same date, 188 shares at $59.12 per share were withheld to cover taxes on these PRSUs and previously reported time-based restricted stock units, reflecting a tax-withholding disposition rather than an open-market sale. After these transactions, he directly owned 10,304.378 common shares and indirectly held 824.5446 shares through a 401(k) plan.
Celanese Corp SVP & CFO Chuck Kyrish reported routine equity compensation activity involving performance-based restricted stock units (PRSUs). He acquired 401 shares of common stock upon PRSU vesting and settlement, then disposed of 179 shares that were withheld to cover taxes, leaving 11,136.476 shares held directly.
Celanese Corp SVP & GC Ashley B. Duffie reported equity award activity involving company common stock. On February 15, 2026, Duffie acquired 618 shares at $0.00 per share through the vesting and settlement of previously granted performance-based restricted stock units under the company’s incentive plan. To cover taxes on this vesting, 183 shares were disposed of at $59.12 per share through share withholding, rather than an open-market sale. After these transactions, Duffie directly held 20,894 common shares and indirectly held 633.396 shares through a 401(k) plan.
Celanese Corporation director Kathryn Hill reported a routine equity compensation transaction. On January 1, 2026, she converted 1,808.351 shares of phantom stock into 1,808.351 shares of Celanese common stock at a price of $0 per share under the company’s 2008 Deferred Compensation Plan.
After this conversion, she directly held 16,808.48 shares of common stock and 1,140.519 phantom stock units. Each phantom stock unit represents the right to receive one share of common stock, payable in shares as provided by the deferred compensation plan.
Celanese Corp’s CEO and President, who also serves as a director, increased his personal stake in the company through a recent stock purchase. On 12/10/2025, he acquired 3,800 shares of Celanese common stock in an open market transaction coded as a purchase at a price of $41.5899 per share. Following this transaction, he beneficially owned 70,448.703 shares directly and an additional 597.0315 shares indirectly through a 401(k) plan. The form was filed for one reporting person, reflecting continued alignment of the senior executive’s holdings with Celanese’s equity.
Celanese Corp insider Chuck Kyrish, the company’s SVP & CFO, reported an equity transaction involving 5,000 shares of Celanese common stock on December 9, 2025, at a weighted average price of about $41.03 per share. After this activity, he beneficially owned 10,914.476 shares directly. The filing notes that the shares were executed in multiple trades within a price range from $40.885 to $41.112, and that detailed trade-by-trade information is available from the reporting person upon request.
Celanese Corp (CE) reported an equity award to Chief Accounting Officer Aaron M. McGilvray. On 11/17/2025, he acquired 2,980 time-based restricted stock units (RSUs) of Celanese common stock at a price of $0 as a compensatory grant. Each RSU represents the right to receive one share of common stock if vesting conditions are met.
The RSUs will vest, subject to continued employment, in two equal installments of 50% on November 17, 2026 and November 17, 2027. Following this grant, McGilvray beneficially owns 10,319.378 shares directly and 798.8018 shares indirectly through a 401(k) plan.
Celanese Corp (CE) reported an equity award to a senior executive. A Form 4 filing shows that an officer serving as SVP & General Counsel received 6,624 shares of Celanese common stock on 11/17/2025 in the form of time-based restricted stock units granted under the company’s Amended and Restated 2018 Global Incentive Plan. The award was recorded at a price of $0 per share, reflecting that it is a compensatory grant rather than an open-market purchase.
Each RSU represents the right to receive one share of common stock, with vesting subject to continued employment. The RSUs will vest 50% on November 17, 2026 and the remaining 50% on November 17, 2027. After this grant, the reporting person directly beneficially owned 20,459 shares, and an additional 624.623 shares were held indirectly through a 401(k) plan.
Celanese Corp (CE) director Kim K.W. Rucker filed a Form 4 reporting the acquisition of 7.29 shares of phantom stock on 11/12/2025, coded “A.” The filing lists a price of $39.12 for the derivative security.
Each phantom share represents the right to receive one share of common stock, with payment in stock under the company’s 2008 Deferred Compensation Plan after the director’s service ends. Following the transaction, 9,514.09 derivative securities were beneficially owned directly.
Celanese Corp (CE) director Deborah J. Kissire reported an acquisition of derivative securities on a Form 4. On 11/12/2025, she acquired 4.54 units of phantom stock (Transaction Code A) at a price of $39.12 per the derivative security entry.
Each phantom stock unit represents the right to receive one share of Common Stock. Following the transaction, she beneficially owned 5,921.288 derivative securities directly. The phantom stock relates to dividend equivalents under the company’s 2008 Deferred Compensation Plan and becomes payable in shares after her service as a director ends.
Celanese (CE) director Jay V. Ihlenfeld filed a Form 4 reporting an acquisition of 7.84 shares of phantom stock on 11/12/2025 (Code A). Following this transaction, he beneficially owns 10,235.059 derivative securities, held directly.
Each phantom share represents the right to receive one share of common stock. The reported phantom stock reflects dividend equivalents on compensation deferred under the company’s 2008 Deferred Compensation Plan and becomes payable in common shares after the director’s service ends, as provided in the plan.
Celanese Corp (CE) reported a Form 4 for director Kathryn Hill. On 11/12/2025, she acquired 2.26 units of phantom stock (transaction code A) at a derivative price of $39.12. After this transaction, she beneficially owned 2,948.87 derivative securities directly.
Each phantom stock unit represents the right to receive one share of common stock. The reported phantom stock reflects dividend equivalents on compensation deferred under the company’s 2008 Deferred Compensation Plan and becomes payable in shares of common stock following the end of her service as a director.
Celanese Corporation (CE) director Timothy Go reported an acquisition of 0.86 phantom stock units on 11/12/2025 (Transaction Code: A). Each phantom stock unit represents the right to receive one share of common stock.
The units reflect dividend equivalents credited under the company’s 2008 Deferred Compensation Plan and become payable in common stock following the end of his service as a director. After this transaction, his directly held derivative securities balance is 1,115.57 units.
Celanese (CE) director Edward G. Galante reported an acquisition of 5.21 phantom stock units on 11/12/2025 under a Form 4 filing. Following this transaction, he beneficially owns 6,802.765 derivative securities.
The transaction was coded A (acquired). Each phantom stock unit represents the right to receive one share of common stock. The reported phantom stock reflects dividend equivalents on compensation deferred under the Company’s 2008 Deferred Compensation Plan and becomes payable in shares of common stock after his service as a director ends. The filing lists a Price of Derivative Security of $39.12.